ArticleJournal of registry management2022
Assessment of Interstate Residential Mobility of SEER Patients: SEER and LexisNexis Residential Address Linkage.
Article in Journal of registry management, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- Court-Documented Adverse Financial Events Before Cancer Diagnosis and Mortality Risk.JAMA network open · 2026Article
- Built Environment Audits Across Space and Time for Estimating Time-Varying Exposures: Cohort Study.JMIR formative research · 2026Article
- The association between long-term PM2.5 exposure and risk for pancreatic cancer: an application of social informatics.American journal of epidemiology · 2025Article
- Towards More Precise Neighborhood Determinants of Health: Collecting Residential Histories as an Important Next Step.Journal of general internal medicine · 2024Article
- Late endocrine diseases in survivors of adolescent and young adult cancer in California: a population-based study.British journal of cancer · 2024Article
- Association of Major Adverse Financial Events and Later-Stage Cancer Diagnosis in the United States.Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024Article
- Using LexisNexis to Improve Social Security Number Information in the New York State Cancer Registry.Journal of registry management · 2023Article
- Utilizing Residential History to Examine Heterogeneous Exposure Trajectories: A Latent Class Mixed Modeling Approach Applied to Mesothelioma Patients.Journal of registry management · 2023Article
- The Associations Between Neighborhood Safety and Address Stability With HbA1c Levels Among Adults With Diabetes.AACE endocrinology and diabetesArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The National Cancer Institute (NCI) Surveillance, Epidemiology, and End Results (SEER) program is continuously exploring opportunities to augment its already extensive collection of data, enhance the quality of reported cancer information, and contribute to more comprehensive analyses of cancer burden. This manuscript describes a recent linkage of the LexisNexis longitudinal residential history data with 11 SEER registries and provides estimates of the inter-state mobility of SEER cancer patients. To identify mobility from one state to another, we used state postal abbreviations to generate state-level residential histories. From this, we determined how often cancer patients moved from state-to-state. The results in this paper provide information on the linkage with LexisNexis data and useful information on state-to-state residential mobility patterns of a large portion of US cancer patients for the most recent 1-, 2-, 3-, 4-, and 5-year periods. We show that mobility patterns vary by geographic area, race/ethnicity and age, and cancer patients tend to move less than the general population.
Indexed as
Identifiers
37260810PMC10229186What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.